银屑病关节炎中与患者报告治疗成功相关的特征
研究纳入单中心178例符合CASPAR分类的银屑病关节炎患者,65%报告治疗成功。多变量logistic回归显示,患者报告的治疗成功与66个肿胀关节数/68个压痛关节数、银屑病体表面积、患者报告结局(疼痛干扰、身体功能、疲劳)及TNF抑制剂治疗独立相关。报告治疗失败者最常见原因为疼痛、疲劳、关节炎症和僵硬。
要点
- 178例银屑病关节炎患者中65%(116/178)报告治疗成功。
- 治疗成功与肿胀/压痛关节数、银屑病BSA、疼痛干扰、身体功能、疲劳及TNF抑制剂治疗独立相关。
- 治疗失败者最常见原因为疼痛(72.4%)、疲劳(60.5%)、关节炎症(52.6%)和僵硬(52.6%)。
核心结论
- 银屑病关节炎患者报告的治疗成功可能通过改善炎症性关节炎、银屑病、疼痛、身体功能和疲劳以及使用TNF抑制剂来实现。
- 患者报告的治疗失败最常见原因是疼痛、疲劳和僵硬症状。
研究设计与样本
- 单中心招募的风湿科诊断且符合CASPAR分类的银屑病关节炎患者。
- 基线访视共178例参与者,平均(SD)CASPAR评分3.7(0.9),年龄51.7(13.5)岁,BMI 31.3(7.2)kg/m2。
- 52%为女性,86.0%为白人。
- 采用描述性和多变量logistic回归分析识别患者报告治疗成功的临床预测因素。
主要发现
- 178例患者中116例(65%)报告治疗成功。
- 76例报告治疗失败的患者中,最常见原因依次为疼痛(n=55,72.4%)、疲劳(n=46,60.5%)、关节炎症(n=40,52.6%)和僵硬(n=40,52.6%)。
- logistic回归模型中有105例参与者具有完整变量数据。
- 控制BMI和人口学特征后,患者报告的治疗成功与66个肿胀关节数/68个压痛关节数、银屑病BSA、患者报告结局(疼痛干扰、身体功能、疲劳)及TNF抑制剂治疗独立相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine characteristics associated with patient-reported treatment success in psoriatic arthritis (PsA). METHODS: Rheumatologist-diagnosed PsA patients fulfilling the CASPAR classification were recruited from a single center. PsA outcome measures included: 66/68 swollen/tender joint counts, Leeds/SPARCC dactylitis/enthesitis indices, psoriasis body surface area (BSA), and patient-reported outcomes (PROs) including PROMIS. The primary outcome was a patient-reported item: 'Today, considering the level of control of your psoriatic arthritis and psoriasis, do you consider your treatment has been successful?'. Descriptive and multivariate logistic regression analyses identified clinical predictors of patient-reported treatment success. Patient-reported reasons for lack of treatment success were explored. RESULTS: A total of 178 participants had a baseline visit. Mean (SD) CASPAR score was 3.7 (0.9), age 51.7 (13.5) years, and BMI 31.3 (7.2) kg/m2. Fifty-two percent were women, and 86.0% white. Treatment success was reported by 116/178 (65%) patients in the analytic cohort. Among 76 patients who reported treatment failure, the most frequently selected reasons for lack of success were pain (n = 55, 72.4%), fatigue (n = 46, 60.5%), inflamed joints (n = 40, 52.6%) and stiffness (n = 40, 52.6%). Overall, 105 participants had complete data across variables in the logistic regression models. Patient-reported treatment success was independently associated with the 66-swollen/68-tender joint counts, psoriasis BSA, PROs (pain interference, physical function, fatigue) and TNF-inhibitor therapy, after controlling for BMI and demographics. CONCLUSION: Patient-reported treatment success in PsA may be achieved through improvement of inflammatory arthritis, psoriasis, pain, physical function, fatigue and the use of TNF-inhibitors. Patients reported treatment failure was most commonly due to symptoms of pain, fatigue and stiffness.
引用
- Samuel C, Finney A, Grader-Beck T, et al. Characteristics associated with patient-reported treatment success in psoriatic arthritis. Rheumatology (Oxford). 2025. PMID: 38460549. doi:10.1093/rheumatology/keae149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。